Haleon plc
No SEC Form 4 filings for $HLN in the last 30 days.
See all $HLN insider activity →According to Reuters, Haleon has launched and priced a three-tranche, $2 billion fixed-rate US dollar bond offering. The company set the terms across multiple maturities, with proceeds intended for general corporate purposes and refinancing needs. The deal provides a new funding source and may affect Haleon’s capital structure and debt costs.
Haleon priced a $2.0 billion three-tranche bond via Haleon US Capital LLC, settling Aug. 21. Tranches: $600m due 2029 at 4.625%, $600m due 2031 at 4.875%, and $800m due 2036 at 5.375%. Haleon plc guarantees principal and interest. Net proceeds will fund repurchase of $1.999bn 3.375% notes due Mar 2027 and remaining for general corporate purposes, according to the company.
Haleon plc said its wholly owned Haleon US Capital LLC priced a $2 billion bond offering with three tranches: $600m 4.625% notes due 2029, $600m 4.875% notes due 2031, and $800m 5.375% notes due 2036, settling Aug. 21, 2026. Proceeds will fund a tender offer to repurchase $1.999bn 3.375% notes due Mar. 2027 and general purposes, with Haleon guaranteeing payments.
Over the past 7 days, alphai's AI scored 6 news stories mentioning HLN (Haleon plc). Coverage has been balanced: 0 bullish, 6 neutral, and 0 bearish.
Recent HLN coverage spans corporate actions, earnings and market movers.
The article signals a new $2 billion USD fixed-rate funding transaction, which can affect near-term liquidity, interest expense expectations, and credit spread sensitivity.
The refinancing extends maturities and increases coupon rates, likely modestly improving near-term liquidity while raising future interest expense.
The capital markets transaction and concurrent tender offer can shift near-term funding costs and reduce near-term refinancing risk.
The deal is a capital-structure event that can shift Haleon’s near-term funding costs and leverage profile, with secondary effects on credit spreads and equity sentiment.
Debt tender offer and planned new bond issuance signal active liability management, potentially affecting near-term funding costs and leverage optics.
alphai scores every news story that mentions HLN with an AI model for sentiment and relevance, and aggregates insider trades from Haleon plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
According to Reuters, Haleon has launched and priced a three-tranche, $2 billion fixed-rate US dollar bond offering. The company set the terms across multiple maturities, with proceeds intended for general corporate purposes and refinancing needs. The deal provides a new funding source and may affect Haleon’s capital structure and debt costs.
1 min readHaleon priced a $2.0 billion three-tranche bond via Haleon US Capital LLC, settling Aug. 21. Tranches: $600m due 2029 at 4.625%, $600m due 2031 at 4.875%, and $800m due 2036 at 5.375%. Haleon plc guarantees principal and interest. Net proceeds will fund repurchase of $1.999bn 3.375% notes due Mar 2027 and remaining for general corporate purposes, according to the company.
2 min readHaleon plc said its wholly owned Haleon US Capital LLC priced a $2 billion bond offering with three tranches: $600m 4.625% notes due 2029, $600m 4.875% notes due 2031, and $800m 5.375% notes due 2036, settling Aug. 21, 2026. Proceeds will fund a tender offer to repurchase $1.999bn 3.375% notes due Mar. 2027 and general purposes, with Haleon guaranteeing payments.
3 min readHaleon plc (LSE/NYSE: HLN) priced a $2bn SEC-registered bond offering by its subsidiary Haleon US Capital LLC, settling 21 Aug 2026. Notes: $600m 4.625% due 2029, $600m 4.875% due 2031, and $800m 5.375% due 2036. Haleon plc guarantees payments and plans to use proceeds to repurchase $1.99935bn 3.375% notes due Mar 2027 and for general purposes.
2 min readHaleon PLC said its subsidiary, Haleon US Capital LLC, is launching a tender offer to buy back up to USD 2.0 billion of 3.375% senior notes due March 2027. Bondholders will receive a price based on reference yield, fixed spread, and accrued interest. The offer expires Aug. 18, 5:00 pm ET, unless extended, to support debt portfolio optimization.
2 min readHaleon plc (LSE/NYSE: HLN) said its wholly owned subsidiary, Haleon US Capital LLC, is making a cash tender offer to buy back all outstanding $1.99935 billion 3.375% fixed rate senior notes due March 2027. Bondholders will receive a price based on a reference yield, fixed spread, and accrued interest, per the offer terms. The company expects it to help manage its debt portfolio.
2 min readHaleon said it will invest about ₹2,000 crore to build its first dedicated manufacturing plant in India, aiming to expand local production and distribution. The company reported mid-teen growth in India in the quarter ended June 2026, with Sensodyne oral health sales up over 20% in the first half. It is also pushing lower-priced packs to drive volume.
3 min readHaleon (HLN) reported first-half results in line with market expectations. The company said organic revenue grew 2.6% and adjusted operating profit rose 8.2% to £1.3bn, supported by strong operating leverage. Haleon also increased its interim dividend, but investors reacted negatively on results day.
2 min readReuters reports Haleon shares fell after concerns about meeting sales targets. The consumer health company said first-half organic revenue grew 2.6% and adjusted operating profit rose to £1.36 billion versus £1.32 billion expected. It needs stronger second-half growth to reach a 4% to 6% medium-term target, amid weak Europe demand and a 6.5% respiratory sales decline.
4 min readHaleon reported adjusted EPS of $0.14 for H1, up 16.7% from $0.12, and sales of $7.533 billion, up 6.0% year over year and far above an analyst consensus of $3.600 billion. The company also announced a new five-year collaboration with Microsoft to expand digital, data and AI capabilities using Azure and Copilot.
6 min read
